| 常用名 | 阿利库单抗 | CAS号 | 1245916-14-6 |
|---|---|---|---|
| 价格 | 纯度 | 95.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Alirocumab (REGN 727) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia[1]. 物理化学性质: CAS号:1245916-14-6 常用中文名:阿利库单抗 常用英文名:Alirocumab 分子式:C6472H9996N1736O2032S42 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:-20℃,避光 |